Response to letter on European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain–Barré syndrome
European Journal of Neurology · 2024
DOI: 10.1111/ene.16230 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Pieter A van Doorn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Guillain-Barre Syndrome, Neurology. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
- Neuromuscular Reference Centre, Department of Neurology, University Hospital Saint-Luc, Brussels, Belgium.
- Department of Neurology, King's College Hospita, London, UK.
ORCID-Profile: Pieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden
Zitieren
APA
van Doorn, P. A., Van den Bergh, P. Y. K., Hadden, R. D. M., & GBS Guideline Task Force (2024). Response to letter on European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain–Barré syndrome. European Journal of Neurology. https://doi.org/10.1111/ene.16230
Vancouver
van Doorn PA, Van den Bergh PYK, Hadden RDM, GBS Guideline Task Force. Response to letter on European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain–Barré syndrome. European Journal of Neurology. 2024. doi:10.1111/ene.16230
BibTeX
@article{vanDoorn2024,
author = {van Doorn, Pieter A and Van den Bergh, Peter Y K and Hadden, Robert D M and GBS Guideline Task Force, GBS Guideline Task Force},
title = {Response to letter on European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain–Barré syndrome},
journal = {European Journal of Neurology},
year = {2024},
doi = {10.1111/ene.16230}
}
EUVIMED